India's Zydus Cadila to make Gilead's potential COVID-19 drug remdesivir
14 Jun 2020

Zydus, listed as Cadila Healthcare, joins other Indian pharmaceutical companies Cipla Ltd, Jubilant Sciences Ltd and privately held Hetero Labs Ltd in signing non-exclusive pacts with Gilead for the drug. 

https://health.economictimes.indiatimes.com/news/pharma/indias-zydus-cadila-to-make-gileads-potential-covid-19-drug-remdesivir/76350429